{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:58:54Z","timestamp":1791669534742,"version":"4.3.4"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.thromres.2022.08.016","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T23:26:18Z","timestamp":1660865178000},"page":"99-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["To clot, or not to clot: The dilemma of hormone treatment options for menopause"],"prefix":"10.1016","volume":"218","author":[{"given":"Renata M.","family":"Booyens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Mart","family":"Engelbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledivia","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2022.08.016_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106633","article-title":"Urinary phthalate metabolite concentrations and serum hormone levels in pre- and perimenopausal women from the Midlife Women's Health Study","volume":"156","author":"Chiang","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.thromres.2022.08.016_bb0010","series-title":"Clinical Manifestations And Diagnosis of Menopause","author":"Casper","year":"2009"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0015","first-page":"70","article-title":"The menopause: the events of the menopause","volume":"96","author":"Mason","year":"1976","journal-title":"R. Soc. Health J."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0020","doi-asserted-by":"crossref","DOI":"10.5070\/D3251042607","article-title":"Bioidentical hormone therapy in menopause: relevance in dermatology","volume":"25","author":"Borda","year":"2019","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.thromres.2022.08.016_bb0025","series-title":"Report of a WHO Scientific Group","first-page":"1","article-title":"Research on the menopause in the 1990s","volume":"866","author":"WHO","year":"1996"},{"key":"10.1016\/j.thromres.2022.08.016_bb0035","series-title":"Serum progesterone","year":"2019"},{"key":"10.1016\/j.thromres.2022.08.016_bb0040","series-title":"Luteinizing Hormone (LH) test: what it is and why it's important","author":"Ellis","year":"2019"},{"key":"10.1016\/j.thromres.2022.08.016_bb0050","author":"WebMD"},{"key":"10.1016\/j.thromres.2022.08.016_bb0055","series-title":"Treatment of menopausal symptoms with hormone therapy [Internet]","year":"2020"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ogc.2018.07.005","article-title":"Vasomotor symptoms across the menopause transition: differences among women","volume":"45","author":"Avis","year":"2018","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ecl.2015.05.001","article-title":"Menopausal symptoms and their management","volume":"44","author":"Santoro","year":"2015","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.thromres.2022.08.016_bb0080","article-title":"Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy","volume":"1\u20136","author":"P\u00e9rez-L\u00f3pez","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.thromres.2022.08.016_bb0085","series-title":"Vaginal Atrophy. StatPearls","author":"Bleibel","year":"2021"},{"key":"10.1016\/j.thromres.2022.08.016_bb0090","author":"Rapaport"},{"key":"10.1016\/j.thromres.2022.08.016_bb0095","author":"Boyles"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2022.08.016_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0028-2243(93)90121-R","article-title":"Subcutaneous hormone replacement therapy","volume":"49","author":"Tzingounis","year":"1993","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.thromres.2022.08.016_bb0105","series-title":"Women are not getting treated for menopausal symptoms","author":"Nelson","year":"2015"},{"key":"10.1016\/j.thromres.2022.08.016_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/757461","article-title":"Estrogen deficiency and the origin of obesity during menopause","volume":"2014","author":"Lizcano","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1210\/jcem.83.6.4934","volume":"83","author":"Anonymous","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a117244","article-title":"Estrogen deficiency and risk of Alzheimer's disease in women","volume":"140","author":"Paganini-Hill","year":"1994","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/ar2791","article-title":"Osteoarthritis associated with estrogen deficiency","volume":"11","author":"Roman-Blas","year":"2009","journal-title":"Arthritis. Res. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2019.01.001","article-title":"Estrogen-deficient skin: the role of topical therapy","volume":"5","author":"Rzepecki","year":"2019","journal-title":"Int.J.Womens Dermatol."},{"key":"10.1016\/j.thromres.2022.08.016_bb0135","article-title":"Venous thromboembolism in women: new challenges for an old disease","volume":"19","author":"de Oliveira","year":"2020","journal-title":"J. Vasc. Bras."},{"key":"10.1016\/j.thromres.2022.08.016_bb0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsbmb.2013.08.010","article-title":"Menopausal hot flashes: mechanisms, endocrinology, treatment","volume":"142","author":"Freedman","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00737-007-0209-5","article-title":"Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages","volume":"10","author":"Deecher","year":"2007","journal-title":"Arch. Womens Ment. Health"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2022.08.016_bb0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(87)90106-9","article-title":"Adaptive changes in thermoregulation and their neuropharmacological basis","volume":"35","author":"Br\u00fcck","year":"1987","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2022.08.016_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biochi.2019.03.023","article-title":"Serotonin-estrogen interactions: what can we learn from pregnancy?","volume":"161","author":"Hudon Thibeault","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.thromres.2022.08.016_bb0160","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-444-64125-0.00012-8","article-title":"Chapter 12 - tryptophan hydroxylase and serotonin synthesis regulation","volume":"31","author":"Kuhn","year":"2020"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1748-1716.2010.02192.x","article-title":"Sex, hormones and neuroeffector mechanisms","volume":"203","author":"Hart","year":"2011","journal-title":"Acta Physiol. (Oxf)."},{"issue":"181","key":"10.1016\/j.thromres.2022.08.016_bb0170","article-title":"The vaginal microenvironment: the physiologic role of lactobacilli","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front.Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0175","article-title":"Dynamics of the vaginal ecosystem\u2014hormonal influences","volume":"3","author":"Farage","year":"2010","journal-title":"Infect.Dis.Res.Treat."},{"key":"10.1016\/j.thromres.2022.08.016_bb0180","series-title":"Fractures are major causes of older women's hospitalizations","author":"Doyle","year":"2014"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.26444\/aaem\/135529","article-title":"Assessment of the effect of estradiol on biochemical bone turnover markers among postmenopausal women","volume":"28","author":"Jamka","year":"2021","journal-title":"Ann. Agric. Environ. Med."},{"issue":"13","key":"10.1016\/j.thromres.2022.08.016_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10133002","article-title":"The treatment gap in osteoporosis","volume":"10","author":"Ayub","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"issue":"Suppl 12B","key":"10.1016\/j.thromres.2022.08.016_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","article-title":"Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration","volume":"118","author":"Stefanick","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0210","series-title":"Animals And Human Society","first-page":"13","article-title":"Chapter 2 - animal attributes exploited by humans (nonfood uses of animals)","author":"Scanes","year":"2018"},{"key":"10.1016\/j.thromres.2022.08.016_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","article-title":"Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action","volume":"142","author":"Bhavnani","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"23","key":"10.1016\/j.thromres.2022.08.016_bb0220","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial carcinoma among users of conjugated estrogens","volume":"293","author":"Ziel","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0230","author":"Ogbru"},{"key":"10.1016\/j.thromres.2022.08.016_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/medicina55090602","article-title":"The controversial history of hormone replacement therapy","volume":"55","author":"Cagnacci","year":"2019","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12905-017-0449-0","article-title":"Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making","volume":"17","author":"Thompson","year":"2017","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.thromres.2022.08.016_bb0245","series-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","author":"Wishart","year":"2006"},{"key":"10.1016\/j.thromres.2022.08.016_bb0250","author":"Sison"},{"issue":"9","key":"10.1016\/j.thromres.2022.08.016_bb0255","first-page":"27","article-title":"Estradiol, estriol, and estrone in HRT cream base","volume":"41","author":"Allen","year":"2021","journal-title":"US Pharm."},{"key":"10.1016\/j.thromres.2022.08.016_bb0260","series-title":"TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA\u2122 (Estradiol and Progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause [Internet]","year":"2018"},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0265","first-page":"771","article-title":"Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference","volume":"39","author":"Martin","year":"1972","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsps.2013.05.004","article-title":"An overview on in situ micronization technique - an emerging novel concept in advanced drug delivery","volume":"22","author":"Vandana","year":"2014","journal-title":"Saudi Pharm. J."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0275","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamainternmed.2020.7232","article-title":"Compounded bioidentical hormone therapy: the National Academies Weigh In","volume":"181","author":"Stuenkel","year":"2021","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0280","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/GME.0000000000001735","article-title":"Compounded bioidentical hormone therapy: new recommendations from the 2020 National Academies of Sciences, Engineering, and Medicine","volume":"28","author":"Stuenkel","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.thromres.2022.08.016_bb0285","series-title":"Current Management of the Menopause","author":"Adlercreutz","year":"2005"},{"issue":"11","key":"10.1016\/j.thromres.2022.08.016_bb0290","first-page":"614","article-title":"Estradiol valerate and estradiol valerate\/dienogest (natazia) tablets: the first four-phasic oral contraceptive","volume":"35","author":"Ndefo","year":"2010","journal-title":"P t."},{"key":"10.1016\/j.thromres.2022.08.016_bb0295","series-title":"PubChem Compound Summary for CID 6291","year":"2021"},{"key":"10.1016\/j.thromres.2022.08.016_bb0300","series-title":"FDA Approves Bijuva Internet: Drugs.com","author":"Raton","year":"2019"},{"key":"10.1016\/j.thromres.2022.08.016_bb0305","series-title":"PubChem Compound Summary for CID 23676225, estrogens, conjugated","year":"2021"},{"key":"10.1016\/j.thromres.2022.08.016_bb0310","series-title":"FDA approved drugs","year":"2021"},{"key":"10.1016\/j.thromres.2022.08.016_bb0315","series-title":"FDA's decision regarding plan B: questions and answers [Internet]","year":"2015"},{"key":"10.1016\/j.thromres.2022.08.016_bb0320","article-title":"Selective estrogen receptor modulators and bone health","volume":"1\u20134","author":"Goldstein","year":"2021","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0325","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3181\/00379727-217-44204","article-title":"Selective estrogen receptor modulators: an alternative to hormone replacement therapy","volume":"217","author":"Bryant","year":"1998","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0083-6729(00)60018-3","article-title":"Mechanism of action of estrogens and selective estrogen receptor modulators","volume":"60","author":"Krishnan","year":"2000","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.thromres.2022.08.016_bb0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mce.2018.06.010","article-title":"Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis","volume":"477","author":"Val\u00e9ra","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"13","key":"10.1016\/j.thromres.2022.08.016_bb0340","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1055\/s-0028-1088304","article-title":"Selective estrogen receptor modulators and phytoestrogens","volume":"74","author":"Oseni","year":"2008","journal-title":"Planta Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0345","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jsbmb.2014.01.016","article-title":"Phytoestrogens as alternative hormone replacement therapy in menopause: what is real, what is unknown","volume":"143","author":"Moreira","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063212","article-title":"Utilization of isoflavones in soybeans for women with menopausal syndrome: an overview","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13697137.2014.966241","article-title":"Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review","volume":"18","author":"Chen","year":"2015","journal-title":"Climacteric"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.016_bb0360","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-020-05476-z","article-title":"Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Sansai","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/09513590903184159","article-title":"Effects of ipriflavone on postmenopausal syndrome and osteoporosis","volume":"26","author":"Zhang","year":"2010","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0370","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/13697137.2018.1467400","article-title":"Progesterone for the prevention and treatment of osteoporosis in women","volume":"21","author":"Prior","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.thromres.2022.08.016_bb0375","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.1986.tb16002.x","article-title":"Estradiol\/progesterone interaction in normal and pathologic breast cells","volume":"464","author":"Mauvais-Jarvis","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.thromres.2022.08.016_bb0380","article-title":"Current evidence of the oncological benefit-risk profile of hormone replacement therapy","volume":"55","author":"D'Alonzo","year":"2019","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/endrev\/bnz001","article-title":"Progesterone and breast cancer","volume":"41","author":"Trabert","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.thromres.2022.08.016_bb0390","series-title":"Progestin. StatPearls","author":"Edwards","year":"2022"},{"key":"10.1016\/j.thromres.2022.08.016_bb0395","series-title":"Female Hormone Regulation Brody's Human Pharmacology","first-page":"410","author":"Ousterhout","year":"2019"},{"key":"10.1016\/j.thromres.2022.08.016_bb0400","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsbmb.2013.11.011","article-title":"Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe?","volume":"142","author":"Stanczyk","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0410","first-page":"364","article-title":"Clinical pharmacology of progestins","volume":"74","author":"Capozzi","year":"2022","journal-title":"MinervaObstet. Gynecol."},{"issue":"4 Suppl","key":"10.1016\/j.thromres.2022.08.016_bb0415","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/cncr.2820710415","article-title":"The estrogenic activity of synthetic progestins used in oral contraceptives","volume":"71","author":"Jordan","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0420","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.2910450131","article-title":"A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity","volume":"45","author":"Coldham","year":"1990","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.016_bb0425","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-2007-978667","article-title":"Effect of norethisterone acetate on estrogen metabolism in postmenopausal women","volume":"32","author":"Seeger","year":"2000","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0430","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/cmt.5.3.229.235","article-title":"Effects of progestogens on the postmenopausal breast","volume":"5","author":"de Ligni\u00e8res","year":"2002","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/15246090050020691","article-title":"Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a cross-sectional survey","volume":"9","author":"Fitzpatrick","year":"2000","journal-title":"J. Womens Health Gend. Based Med."},{"key":"10.1016\/j.thromres.2022.08.016_bb0440","author":"Price"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in human","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.thromres.2022.08.016_bb0450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2012.12.014","article-title":"The structural biology of oestrogen metabolism","volume":"137","author":"Thomas","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0455","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1210\/en.2003-0192","article-title":"Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1754045313503635","volume":"19","author":"Mittal","year":"2013","journal-title":"Menopause Int."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0465","first-page":"12","article-title":"Effect of norethisterone acetate on markers of inflammation in postmenopausal women receiving estradiol","volume":"14","author":"Zegura","year":"2005","journal-title":"Gynaecol.Perinatol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0470","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0475","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1538-7836.2010.03953.x","article-title":"The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy","volume":"8","author":"Bagot","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0480","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0485","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0490","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jemt.22378","article-title":"Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: a qualitative investigation","volume":"77","author":"Swanepoel","year":"2014","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.thromres.2022.08.016_bb0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2016.08.022","article-title":"The clinical relevance of altered fibrinogen packaging in the presence of 17\u03b2-estradiol and progesterone","volume":"146","author":"Swanepoel","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2022.08.016_bb0500","series-title":"Simple Coagualtion Cascade With Mnemonics","author":"Shrestha","year":"2017"},{"issue":"14","key":"10.1016\/j.thromres.2022.08.016_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145168","article-title":"COVID-19: the rollercoaster of fibrin(ogen), D-dimer, von Willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes","volume":"21","author":"Grobler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.thromres.2022.08.016_bb0510","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0735-1097(02)02565-2","article-title":"Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women","volume":"40","author":"Rabbani","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2 Pt 1","key":"10.1016\/j.thromres.2022.08.016_bb0515","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.thromres.2022.08.016_bb0520","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0525","first-page":"237","article-title":"Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors","volume":"249","author":"Gotts\u00e4ter","year":"2001","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0530","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.03976.x","article-title":"Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial","volume":"120","author":"Cushman","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.016_bb0535","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0540","doi-asserted-by":"crossref","first-page":"32188","DOI":"10.1038\/srep32188","article-title":"Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity","volume":"6","author":"Bester","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.03061.x","article-title":"Interleukin 6 and haemostasis","volume":"115","author":"Kerr","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096497","article-title":"The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor","volume":"9","author":"Govender","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0555","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/endo.140.6.6763","article-title":"Expression of the Interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture*","volume":"140","author":"Maret","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.thromres.2022.08.016_bb0560","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/ATVBAHA.106.137455","article-title":"Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells","volume":"27","author":"Zhao","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0565","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41598-019-39056-x","article-title":"Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation","volume":"9","author":"Page","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0570","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1160\/TH09-03-0169","article-title":"Short-term ethinyl estradiol treatment suppresses inferior caval vein thrombosis in obese mice","volume":"102","author":"Cleuren","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0575","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5122(02)00182-2","article-title":"Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women","volume":"43","author":"Goudev","year":"2002","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0580","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000115383.49802.0c","article-title":"Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women","volume":"24","author":"Wakatsuki","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.016_bb0585","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/hc1202.105945","article-title":"Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen","volume":"105","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0590","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0736-4679(99)00135-3","article-title":"The C-reactive protein","volume":"17","author":"Clyne","year":"1999","journal-title":"J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0595","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.016_bb0600","first-page":"465","article-title":"P-selectin and its role in some diseases","volume":"63","author":"Polek","year":"2009","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.016_bb0605","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","article-title":"C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant","volume":"25","author":"Singh","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0610","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5122(02)00039-7","article-title":"Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry","volume":"42","author":"Perry","year":"2002","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0615","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1067\/mob.2002.122414","article-title":"Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations","volume":"186","author":"Skouby","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0620","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.maturitas.2005.05.006","article-title":"Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels","volume":"53","author":"Gol","year":"2006","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0625","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2005.06.011","article-title":"The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial","volume":"185","author":"Hu","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.thromres.2022.08.016_bb0630","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.ATV.19.12.2993","article-title":"Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: a 2-year, placebo-controlled study","volume":"19","author":"de Valk-de Roo","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0635","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1160\/TH10-03-0201","article-title":"Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens","volume":"104","author":"Kelly","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0640","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/gerona\/59.8.M827","article-title":"The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women","volume":"59","author":"Prestwood","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0645","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6118\/jmm.2019.25.1.49","article-title":"The effects of menopausal hormone therapy on serum level of C-reactive protein in postmenopausal Korean women","volume":"25","author":"Shin","year":"2019","journal-title":"J Menopausal Med."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0650","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2006.11.040","article-title":"Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study","volume":"87","author":"Goldstein","year":"2007","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2014.05.005","article-title":"Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player","volume":"62","author":"Bode","year":"2014","journal-title":"Vasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0660","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J. Anaesth."},{"issue":"14","key":"10.1016\/j.thromres.2022.08.016_bb0665","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2017-02-767079","article-title":"Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex","volume":"130","author":"Kamikubo","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0670","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2012.09.006","article-title":"Norethisterone acetate alters coagulation gene expression in vitro in human cell culture","volume":"131","author":"Brosnan","year":"2013","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1631\/jzus.B1000106","article-title":"Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy","volume":"12","author":"Ruszkowska","year":"2011","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"15","key":"10.1016\/j.thromres.2022.08.016_bb0680","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/01.CIR.103.15.1961","article-title":"Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women","volume":"103","author":"Koh","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0685","first-page":"926","article-title":"Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells","volume":"83","author":"Krikun","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0690","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211462","article-title":"Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-\u03baB signaling","volume":"14","author":"Ito","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2022.08.016_bb0700","series-title":"Biochemistry, Antithrombin III. StatPearls","author":"Hsu","year":"2021"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0705","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0010-7824(93)90119-R","article-title":"Effect of norethisterone acetate on serum lipid and lipoprotein parameters as well as on blood coagulation in female monkeys (M. fascicularis)","volume":"48","author":"Lehmann","year":"1993","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0710","first-page":"330","article-title":"Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women","volume":"77","author":"Bonduki","year":"1998","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2004.09.014","article-title":"Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature","volume":"116","author":"Cosman","year":"2005","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.016_bb0720","first-page":"337","article-title":"Nonhormonal management of postmenopausal women: effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular risk serum profile","volume":"40","author":"Mainini","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0725","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/OGX.0b013e31828baef9","article-title":"Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications","volume":"68","author":"Gizzo","year":"2013","journal-title":"Obstet. Gynecol. Surv."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0730","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(98)00022-7","article-title":"Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men","volume":"137","author":"Giri","year":"1998","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0735","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jog.13306","article-title":"Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users","volume":"43","author":"Melhado-Kimura","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0740","first-page":"1022","article-title":"Evaluation of the effect of depot medroxyprogesterone acetate injections as contraceptives on some coagulation parameters","volume":"8","author":"Al-Obaidy","year":"2014","journal-title":"J. Pharm. Res."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.016_bb0745","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.ATV.0000168421.13467.82","article-title":"Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition","volume":"25","author":"Dahlb\u00e4ck","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.016_bb0750","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1073\/pnas.91.7.2728","article-title":"Protein S binds to and inhibits factor Xa","volume":"91","author":"Heeb","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0755","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/17455057.2.5.761","article-title":"Venous thrombosis and oral contraceptives: current status","volume":"2","author":"Tchaikovski","year":"2006","journal-title":"Womens Health (Lond)."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.016_bb0760","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nut.2007.10.009","article-title":"Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women","volume":"24","author":"Rios","year":"2008","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0765","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0770","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamainternmed.2013.11074","article-title":"Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens","volume":"174","author":"Smith","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"11","key":"10.1016\/j.thromres.2022.08.016_bb0775","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/annonc\/mdh437","article-title":"Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?","volume":"15","author":"Erman","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.thromres.2022.08.016_bb0780","series-title":"Consultative Hemostasis And Thrombosis","first-page":"205","article-title":"14 - thrombophilia: clinical and laboratory assessment and management","author":"Heit","year":"2013"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0785","first-page":"9","article-title":"Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives","volume":"84","author":"Meijers","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.016_bb0790","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jfma.2013.11.001","article-title":"Effects of high-dose phytoestrogens on circulating cellular microparticles and coagulation function in postmenopausal women","volume":"114","author":"Cheng","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0795","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/jc.2004-1428","article-title":"Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women","volume":"90","author":"Teede","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0800","first-page":"1127","article-title":"Medroxyprogesterone acetate (MPA) increases pai-1 secretion from HUVEC and elevates the plasma-levels of PAI-I in-vivo","volume":"1","author":"Serizawa","year":"1994","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.016_bb0805","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.ATV.20.5.1396","article-title":"Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis","volume":"20","author":"Giltay","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"18","key":"10.1016\/j.thromres.2022.08.016_bb0810","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.016_bb0815","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3476(99)70171-X","article-title":"Acquired protein S deficiency caused by estrogen treatment of tall stature","volume":"135","author":"van Ommen","year":"1999","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.016_bb0820","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9378(72)90551-0","article-title":"Progestational agents and blood coagulation. IV. Changes induced by progestogen alone","volume":"113","author":"Mink","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0825","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","article-title":"Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity","volume":"11","author":"Dawson","year":"1991","journal-title":"Arterioscler. Thromb."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.016_bb0830","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2022.08.016_bb0835","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1538-7836.2006.02216.x","article-title":"Prothrombin A19911G polymorphism and the risk of venous thromboembolism","volume":"4","author":"Martinelli","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.016_bb0840","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1538-7836.2006.02257.x","article-title":"The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case-control study","volume":"4","author":"Chinthammitr","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0845","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2005.01572.x","article-title":"Inherited defects of coagulation factor V: the thrombotic side","volume":"4","author":"Vos","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"22","key":"10.1016\/j.thromres.2022.08.016_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10225381","article-title":"TEG(\u00ae), microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy","volume":"10","author":"Laubscher","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.016_bb0855","first-page":"59","article-title":"Metabolic disorders in menopause","volume":"14","author":"Stachowiak","year":"2015","journal-title":"Prz Menopauzalny"},{"issue":"20","key":"10.1016\/j.thromres.2022.08.016_bb0860","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","article-title":"Inflammation, obesity, and thrombosis","volume":"122","author":"Samad","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.016_bb0865","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnins.2015.00037","article-title":"Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods","volume":"9","author":"Barth","year":"2015","journal-title":"Front. Neurosci."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:34Z","timestamp":1758736234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":167,"alternative-id":["S0049384822003589"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To clot, or not to clot: The dilemma of hormone treatment options for menopause","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}